Theratechnologies Inc T.TH

Alternate Symbol(s): THTX

Healthcare Biotechnology

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.

TSX:TH - Post by User

Theratechnologies Inc > Any opinions as to how well the offering is selling?

<< Previous

Bullboard Posts

Next >>

Post by juniper88on Oct 30, 2023 2:11pm

169 Views

Post# 35707663

Any opinions as to how well the offering is selling?

Would we see the offer (the public portion) reflected in the daily volume?

And can we ascertain anything from the fact that THTX has been trading less than 95 cents/share during this time?

I have seen other companies do offerings and the share price was identical to the offering price.

I guess I am hopeful that this will be a flop.

<< Previous

Bullboard Posts

Next >>

How one company is disrupting PoC testing